Login / Signup

Research progress in tumor targeted immunotherapy.

Yuelin FangAihua YuLei YeGuangxi Zhai
Published in: Expert opinion on drug delivery (2021)
Immunotherapy can restore anti-tumor immunity in the tumor microenvironment and produce a lasting immune surveillance effect. Smart multifunctional nano delivery system can effectively combine targeted therapy with immunotherapy, which has attracted extensive attention. With the deepening of research, more and more tumor-targeted immunotherapy enter into the clinical trial phases, especially antibodies and inhibitors. Tumor-targeted immunotherapy is a promising approach for conquering cancer and bringing hope for human health.
Keyphrases
  • human health
  • cancer therapy
  • clinical trial
  • risk assessment
  • drug delivery
  • public health
  • squamous cell carcinoma
  • climate change
  • working memory
  • open label
  • young adults
  • phase iii